|
Don’t Miss Out: Early Access to Clinical Study Highlights
AAP 2026 Corporate Forum: Advancing Science and Clinical Practice with a Novel Biomaterial
An invitation from Jeanne Ambruster, Founder & CEO, The Avenues Company
We are thrilled to invite you to a special Corporate Forum at the AAP meeting in Seattle featuring the OsteoGen Plug®.
This session will spotlight this novel biomaterial that is generating real excitement across the periodontal community while showcasing the value of practice-based research at its best.
Mark your calendar:
Corporate Forum at the 2026 Annual Meeting
Thursday, October 29 at 3:10 PM
Seattle Convention Center – Arch Building, Room 618
Session 1: 3:10 PM – 3:55 PM
Session 2: 4:15 PM – 5:00 PM (Panel discussion with all speakers follows Session II.)
Add to Calendar
Real-World Evidence You Can Trust
This forum offers a first look at key highlights from a multi-center, randomized controlled clinical trial conducted through The McGuire Institute's practice-based research network. The study measured OsteoGen Plug® against a gold standard control, providing the rigorous evidence periodontists expect and deserve.
What makes this research particularly valuable is that clinicians ran the trial across diverse practice environments. This is real-world evidence you can trust and apply in practice immediately.
Meet the Investigators
You will hear directly from some members of the research team. Principal investigator Dr. Irina Dragan will share insights from the study, and Dr. Michael McGuire and Dr. Rachel Schallhorn will also present as investigators, sharing their own findings and clinical observations. Together, they will walk you through high-level clinical, radiographic, and histologic data—showing how this biomaterial performs across multiple measures of regenerative success.
What You Will Take Away
The session will explore expanded clinical indications for the OsteoGen Plug®. You will see where this technology makes a real difference in everyday regenerative situations, and the potential of this product will be demonstrated and confirmed by our experienced investigators.
This is your chance to learn about breakthrough research before full publication, directly from the investigators involved in the study.
 About Jeanne Ambruster
Founder & CEO, The Avenues Company; Founding Board Member, The McGuire Institute
Jeanne is a scientist who has spent her career advancing oral health innovations. She began at W.L. Gore's Medical Division in 1981, where she patented GTR/GBR membranes. In 2000, she founded The Avenues Company, a product, market, and business development firm specializing in translating devices, biologics, and diagnostics from benchtop to clinic.
Jeanne serves as a founding board member of The McGuire Institute, which conducts practice-based research in dentistry. She also serves on the board of the AAPF, the Operating Committee for the Michigan-Pittsburgh-Wyss Regenerative Medicine Center, and the Dean's Advisory Group at Harvard School of Dental Medicine, where she previously served as Expert in Residence and leads efforts on the H-CREDENT grant introducing dental students to practice-based research.
 About Dr. Michael McGuire
Dr. McGuire is the author of over eighty-five peer reviewed and published scientific manuscripts, an unparalleled achievement for someone in full time private practice. He is the founder and chairman of the McGuire Institute, a nationwide not-for-profit practice-based clinical research network.
His research has received the American Academy of Periodontology’s highest recognition for excellence, four times earning the Robinson Regeneration Award and twice the Clinical Research Award. He is also the recipient of the Academy’s prestigious Master Clinician Award and the Academy’s highest honor, the Gold Medal Award. In 2015 he received the William J. Gies Periodontology Award for his distinguished achievement in periodontology.
Dr. McGuire is past Chairman of the American Board of Periodontology. He has served as president of numerous dental organizations, including the American Academy of Periodontology and the American Academy of Periodontology Foundation. He is a voting member of the FDA Dental Products Devices Panel.
Dr. McGuire received a bachelor’s degree in psychology from Baylor University. He earned both his D.D.S. and Certificate of Periodontics from the Emory University School of Dentistry. Emory University recognized Dr. McGuire with their Distinguished Alumnus Award in 2009.
About Dr. Irina Dragan
Dr. Irina Dragan is board certified and an examiner for the American Board of Periodontology and Implant Dentistry. She is part-time faculty in postgraduate periodontics at Harvard School of Dental Medicine and an adjunct associate professor of periodontology at Tufts University School of Dental Medicine (TUSDM). Her clinical practice is focused on practice-based research and is limited to periodontology and implant dentistry at The Perio Studio, in downtown Boston, MA.
 About Dr Rachel Schallhorn
Dr. Rachel Schallhorn maintains a private practice in periodontics and implant dentistry in Aurora, Colorado. She is diplomate of the American Board of Periodontology and is actively involved in practice-based clinical research. Dr. Schallhorn has authored and contributed to several scientific publications and has lectured both nationally and internationally.
Join us in Seattle to learn about the future of regenerative dentistry.
AAP 2026 Annual Meeting – Thursday, October 29th
Session 1 — 3:10pm to 3:55pm
Session 2 — 4:15pm to 5:00pm (Panel discussion follows Part II)
Room #618, Arch Building
We can't wait to share what we have learned.
|
